Drug Discovery Strategies and Methods

Inbunden, Engelska, 2003

2 549 kr

Tillfälligt slut

Beskrivning

Navigate the complex and multidisciplinary path of drug discovery procedures with Drug Discovery Strategies and Methods-a well-organized and timely reference that analyzes methods in target identification and validation, lead detection, compound optimization, and biological testing. This volume addresses challenges encountered during the discovery of new pharmaceutical candidates including the use of cutting-edge techniques utilized in drug design and development. It considers key elements in the drug design cycle ranging from appropriateness of targets and disease models to compound characterization, safety, and efficacy and the role of protein crystallography in structure-based drug design.

Produktinformation

Utgivningsdatum:2003-11-04
Mått:210 x 280 x undefined mm
Vikt:612 g
Format:Inbunden
Språk:Engelska
Antal sidor:348
Förlag:Taylor & Francis Inc
ISBN:9780824706913

Utforska kategorier

Kemi inom Naturvetenskap och teknik
Medicinsk utrustning och medicinska tekniker inom Medicin
Biologi inom Naturvetenskap och teknik

Mer om författaren

Alexandros Makriyannis University of Connecticut, Storrs, Connecticut, U.S.A.

Innehållsförteckning

1 Protein Crystallography in Structure based Drug Design, 2 SRS Homology-2 Domains and Structure-Based, Small Molecule Library Approaches to Drug Discovery, 3Three-Dimensional Structure of the Inhibited Catalytic Domain of Human Stromelysin-1 by Heteronuclear NMR Spectroscopy, 4 Cannabinergics: Old and New Therapeutic Possibilities, 5 Development of PET and SPECT Radioligands for Cannabinoid Receptors, 6 Structural and Pharmacological Aspects of Peptidomimetics, 7 Linkers and Resins for Solid-Phase Synthesis, 8 Allosteric Modulation of G Protein -Coupled Receptors: Implications for Drug Action 9 Protein Misfolding and Neurodegenerative Disease: Therapeutic Opportunities 10 Uncoating and Adsorption Inhibitors of Rhinovirus Replication, 11 Profiles of Prototype Antiviral Agents Interfering with the Initial Stages of HIV Infection